Incyte Corporation (NASDAQ:INCY) Q4 2025 Earnings Call Transcript
Operator: Greetings and welcome to the Incyte Fourth Quarter and Year End 2025 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Incyte Corp (INCY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 3,978,332 | $392,939,852 | -13% | 0.61% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,094,460 | $305,639,814 | -1% | 0.18% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,072,491 | $105,929,937 | +6587% | 0.1% |
| 4. | Bridgewater Associates Ray Dalio | 328,590 | $32,454,834 | +151% | 0.12% |
| 5. | ARK Investment Management Catherine D. Wood | 136,950 | $13,526,537 | -8% | 0.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $73.31 | 175,795 | $12,887,302.92 | 33,419,055 | 2022-03-10 | Filing | |
| $73.31 | 14,490 | $1,062,243.06 | 2,941,147 | 2022-03-10 | Filing | |
| $71.95 | 1,017 | $73,176.91 | 33,243,260 | 2022-03-10 | Filing | |
| $71.95 | 84 | $6,044.11 | 2,926,657 | 2022-03-10 | Filing | |
| $71.90 | 25,107 | $1,805,125.51 | 33,242,243 | 2022-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $109.07 | 10,856 | $1,184,063.92 | 66,132 | 2026-01-07 | Filing | |
| $101.70 | 15,634 | $1,589,977.80 | 34,203 | 2026-01-05 | Filing | |
| $100.00 | 2,774 | $277,400.00 | 22,973 | 2025-12-19 | Filing | |
| $98.25 | 600 | $58,950.00 | 22,973 | 2025-12-18 | Filing | |
| $97.26 | 4,323 | $420,454.98 | 27,507 | 2025-12-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,911,434 | $1,966,652,336 | 0.03% | |
| 2. | 18,327,923 | $1,810,248,917 | 0.03% | |
| 3. | 13,261,742 | $1,309,862,257 | 0.71% | |
| 4. | 9,656,403 | $953,762,924 | 0.03% | |
| 5. | 4,993,012 | $491,499,628 | 0.03% |
News See All
TD Cowen Keeps Buy Rating on Incyte (INCY), Cites Roadmap to Triple Non-Jakafi Revenue by 2029
Incyte Corporation (NASDAQ:INCY) is one of the most undervalued quality stocks to buy right now.
13 Most Undervalued Quality Stocks to Buy Right Now
On January 22, Dan Ives, Global Head of Technology Research at Wedbush Securities, and Jeff Kilburg, Founder & CEO of KKM Financial, appeared on CNBC to suggest that easing volatility, AI-driven tech ...
Analysts Differ in Opinion on Jakafi Drug Maker Incyte (INCY)
Incyte Corp (NASDAQ:INCY) is one of the most undervalued stocks to buy and hold for 5 years.
10 Most Undervalued Stocks to Buy and Hold for 5 Years
The ability to pick undervalued stocks is a valuable skill to have for investing in equities, because it helps you maximize their earning potential from market upswings like the one that Ed Yardeni, the...
Incyte (INCY) Extends Climb, Hits New High on Bullish Coverage
The upgrade followed Incyte Corp.’s (NASDAQ:INCY) third quarter earnings results last week, where it quadrupled its net income to $424 million from $106 million in the same period last year.
Incyte Corporation (NASDAQ:INCY) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Incyte Third Quarter 2025 Earnings Conference Call webcast [Operator Instructions]. As a reminder, this conference is being recorded.
Bank of America Securities Maintains a Buy on Incyte Corporation (INCY)
Incyte Corporation (NASDAQ:INCY) is one of the most profitable biotech stocks to buy.
9 Most Profitable Biotech Stocks to Buy
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
Incyte (INCY) Price Target Lifted on CALR Antibody Program Optimism
Incyte Corporation (NASDAQ:INCY) ranks among the best biotech stocks to buy.
Hedge Fund Resource Center Billionaire Hedge Funds
